Sotera Health CoSHC
ASignal's systematic analysis rates SHC as Neutral.
Reflects the latest available analysis · analyzed Sep 2, 2026
The case on SHC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong gross margin (54.97%) indicating pricing power
- High return on equity (27.78%) suggesting efficient capital use
- Operating cash flow positive at $292.19M
- Forward P/E of 17.63x suggests lower expected valuation vs current
- Debt-to-equity ratio of 3.41x is high, indicating elevated financial risk
- MACD below signal line with negative histogram, suggesting weakening momentum
- Price trading below 20-day and 50-day moving averages
- Value score of 0.30 indicates expensive valuation relative to growth
See the full verdict on SHC
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes SHC
Most investors never get a second opinion, let alone several. ASignal runs SHC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.